McKesson Co. (NYSE:MCK) Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC trimmed its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 4.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,093 shares of the company's stock after selling 2,697 shares during the quarter. Neuberger Berman Group LLC's holdings in McKesson were worth $35,957,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Millstone Evans Group LLC acquired a new stake in McKesson in the fourth quarter valued at $28,000. Synergy Asset Management LLC purchased a new position in McKesson in the fourth quarter valued at about $32,000. Crews Bank & Trust acquired a new stake in shares of McKesson in the 4th quarter worth approximately $33,000. Atala Financial Inc acquired a new position in McKesson during the fourth quarter worth $34,000. Finally, Graney & King LLC acquired a new stake in McKesson in the fourth quarter valued at $38,000. Institutional investors and hedge funds own 85.07% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently commented on MCK. Morgan Stanley increased their price objective on shares of McKesson from $642.00 to $745.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Bank of America raised their price objective on shares of McKesson from $665.00 to $755.00 and gave the stock a "buy" rating in a research note on Friday. Cfra Research lowered McKesson from a "moderate buy" rating to a "hold" rating in a research note on Friday, April 4th. Wells Fargo & Company boosted their price target on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Finally, Mizuho lifted their price objective on McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research report on Thursday, April 3rd. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, McKesson currently has an average rating of "Moderate Buy" and an average target price of $668.50.

Remove Ads

McKesson Trading Down 0.2 %

MCK traded down $1.55 during trading on Tuesday, hitting $692.43. 670,498 shares of the company's stock were exchanged, compared to its average volume of 881,256. The stock has a 50 day moving average price of $644.47 and a 200 day moving average price of $595.30. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $728.32. The firm has a market cap of $86.78 billion, a P/E ratio of 31.70, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Analysts forecast that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd were paid a dividend of $0.71 per share. The ex-dividend date was Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.41%. McKesson's dividend payout ratio is presently 13.00%.

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 188 shares of the company's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the sale, the executive vice president now owns 1,051 shares in the company, valued at $640,679.09. This represents a 15.17 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares of the company's stock, valued at $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 18,110 shares of company stock valued at $10,855,706. 0.11% of the stock is currently owned by insiders.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.